全球鞘內泵市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，脊髓內泵市場規模將從 2025 年的 4.2299 億美元成長至 7.098 億美元，2026 年至 2034 年的複合年成長率為 5.92%。

鞘內幫浦可將藥物直接輸送至腦脊髓液，作為一種標靶給藥方案，在治療慢性疼痛和痙攣方面正日益受到關注。推動這一成長的因素包括：臨床上需要減少全身鴉片類藥物暴露，同時維持有效的鎮痛效果；以及可程式設計控制器和長壽命電池等設備的改進。慢性疼痛疾病盛行率的不斷上升、適應症的擴大（包括癌症疼痛）以及對神經調控療法日益成長的需求，都在推動市場穩步擴張，並促使人們投資研發新一代的鞘內泵系統。

關鍵市場促進因素包括臨床指南的轉變，建議局部用藥治療難治性疼痛；強力的證據表明局部用藥可改善生活品質；以及醫保報銷計劃的擴大，這些計劃認可了局部用藥相比全身治療的長期成本優勢。諸如兼容MRI的泵、遠端編程和改進的感染控制能力等技術進步正在降低臨床應用障礙。然而，在外科基礎設施有限的地區，移植手術的複雜性、成本考量以及治療維持所需的專業設施等因素限制了市場擴張的加速。

未來前景樂觀。隨著製造商專注於安全性、遠端監測和簡化更換通訊協定以減少患者就醫次數，預計將保持溫和但穩定的複合年成長率。拓展新興市場將取決於培訓、報銷和醫院投資。與疼痛管理網路建立合作關係、創建真實世界數據 (RWE) 以及商品搭售服務（包括器械、植入和後續護理）將是擴大應用範圍和改善患者就醫體驗的關鍵策略。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球鞘內幫浦市場：依類型分類

• 市場分析、洞察與預測
• Baclofen
• Bupivacaine
• 可樂定
• 氫可酮
• 地可諾胜肽
• 其他

第5章 全球鞘內幫浦市場：依應用分類

• 市場分析、洞察與預測
• 痙攣
• 疼痛

第6章 全球鞘內幫浦市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Medtronic Plc
  • Codman & Shurtleff（A Johnson & Johnson Company）
  • Medallion Therapeutics
  • Arrow International Inc
  • Tricumed GmbH
  • Smiths Medical
  • Teleflex Incorporated
  • Flowonix Medical
  • Baxter International Inc
  • Durect Corporation

The Intrathecal Pumps Market size is expected to reach USD 709.80 Million in 2034 from USD 422.99 Million (2025) growing at a CAGR of 5.92% during 2026-2034.

Intrathecal pumps which deliver medication directly to the cerebrospinal fluid-are gaining traction as targeted drug-delivery solutions for chronic pain and spasticity. Growth stems from the clinical need to reduce systemic opioid exposure while maintaining effective analgesia, and from device improvements such as programmable controllers and longer battery life. Increasing prevalence of chronic pain conditions, expanding indications (including cancer pain), and rising demand for neuromodulation therapies are driving steady market expansion and investment in next-generation pump systems.

Key market drivers include shifting clinical guidelines favoring localized delivery for refractory pain, stronger evidence supporting quality-of-life gains, and reimbursement frameworks that increasingly recognize long-term cost savings versus systemic therapies. Technological advances-MRI-safe pumps, remote programming, and improved infection-control features-are lowering clinical barriers. Nevertheless, implantation complexity, cost considerations, and the need for specialized centers to manage therapy maintenance temper acceleration in regions with limited surgical infrastructure.

Future prospects are positive: expect modest but steady CAGR as manufacturers focus on safety, remote monitoring, and simplified refill protocols that reduce clinic visits. Expansion into emerging markets will depend on training, reimbursement, and hospital investment. Collaboration with pain-management networks, real-world evidence generation, and bundling of services (device, implant, follow-up care) will be key strategies to broaden adoption and improve patient access.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Baclofen
• Bupivacaine
• Clonidine
• Morphine
• Ziconotide
• Others

By Application

• Spasticity
• Pain

COMPANIES PROFILED

• Medtronic plc, Codman Shurtleff a Johnson Johnson company, Medallion Therapeutics, Arrow International Inc, Tricumed GmbH, Smiths Medical, Teleflex Incorporated, Flowonix Medical, Baxter International Inc, Durect Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRATHECAL PUMPS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Baclofen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bupivacaine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Clonidine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Morphine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Ziconotide Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRATHECAL PUMPS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Spasticity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRATHECAL PUMPS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL INTRATHECAL PUMPS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Medtronic Plc
  • 8.2.2 Codman & Shurtleff (A Johnson & Johnson Company)
  • 8.2.3 Medallion Therapeutics
  • 8.2.4 Arrow International Inc
  • 8.2.5 Tricumed GmbH
  • 8.2.6 Smiths Medical
  • 8.2.7 Teleflex Incorporated
  • 8.2.8 Flowonix Medical
  • 8.2.9 Baxter International Inc
  • 8.2.10 Durect Corporation